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Objective: To report cases of neurocysticercosis (NCC) from three neighboring districts
of Andhra Pradesh state in India where NCC burden was never explored before.
Methods: A total of 160 patients presenting with recent onset seizures were recruited
from neurology, general medicine, and pediatric outpatient clinics of a local major tertiary
care teaching hospital serving above districts during the period 2011–2014. Brain imaging
was performed in all the above cases. A commercial immunoglobulin G-ELISA kit
(sensitivity = 85%; speciﬁcity = 94%) was employed for the serological diagnosis of NCC.
Results: The recruited patients presented with generalized, simple partial, and complex
partial seizures (55%, 31.25% and 13.75% respectively). NCC was diagnosed in 44 of
160 (27.5%) seizure cases based on imaging characteristics, and a positive serum anti-
body ELISA. No association was detected between seropositivity with the number and
location of the lesion(s) in the brain.
Conclusions: The possible potentiality of NCC could be identiﬁed as an underlying
cause of the recent onset of seizures in this region as explored in the present study. It is
recommended that NCC should be suspected as one of the major differential in every
recent onset seizure with or without a radio imaging supportive diagnosis, especially in
areas endemic for taeniasis/cysticercosis.1. Introduction
The central nervous system isknown tobe themost common site
of infection with Taenia solium (T. solium) metacestode larvaecausing neurocysticercosis (NCC). This is a major public health
problem in tropical developing countries where it affects patients of
all ages [1]. Human gets infected either by accidental ingestion of
T. solium eggs through contaminated food/vegetables or due to
endogenous autoinfection particularly in subjects who are carriers
of the adult worm in their intestine; by either means, eggs
containing the hexacanth larvae disseminate hematogenously to
the brain developing into metacestode larvae or cysts [2].
The clinical manifestations of NCC are non-speciﬁc and
varied, depending on the number of lesions as well as the
developmental stage of the parasite. Seizures are the commonest
manifestation, occurring in 50%–80% of patients [3,4]. NCC is
considered to be the single most common cause of epilepsy in
the developing countries which are known to be endemic for
T. solium taeniasis/cysticercosis [5,6]. A recent meta-analysis
summarizes the proportion of NCC among patients withrticle under the CC BY-NC-ND license (http://
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Figure 1. Location map of the study area including three districts (Srika-
kulam, Vizianagaram and Vishakhapatnam) of Andhra Pradesh state in
India.
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nearly one-third of PWE are living with T. solium cystic lesions
in their brain [7]. NCC was found to be associated with
approximately one-third of all cases presenting with active epi-
lepsy in either urban or rural regions as per a study reported from
Vellore district of Tamil Nadu, India [8]. The pleomorphic and
unpredictable course of NCC could be related to either the
parasite factors (viz., biological stage and numbers) or the host
immunogenetic factors [9].
T. solium cysticercosis occurs in many resource-poor
countries, especially those with warm and tropical climates of
Latin America, Asia and Sub-Saharan Africa [10]. NCC is a
common chronic neurological disorder with sero-prevalence
of 0.1%–6% in India and 0.02%–6% in China, Korea, Viet-
nam [11]. In a recent Indian study, 89.66% cases having
neurological manifestations with inﬂammatory granulomas
were found consistent with diagnosis of NCC [12]. However,
the serodiagnostic conﬁrmation was not performed in those
cases. There are many provinces where reports are still
unavailable or scanty thereby underestimating its actual
burden in this country [6].
The present study was done in Andhra Pradesh, a southern
coastal state in India, previously known to be endemic for
T. solium cysticercosis in pig and man where various forms of
cysticercosis in man have been reported [13–16]. However, no
laboratory conﬁrmed case was reported so far from the studied
three neighboring districts (Visakhapatnam, Vizianagaram,
Srikakulam). Either due to lack of a conﬁrmatory diagnosis or
unawareness about the necessity of its documentation, there
was a lack of reported cases or notiﬁcations which probably
had given the false impression about its low prevalence or
rareness in this region. Keeping this into consideration, the
present study was conducted with the objective to address the
problem of NCC among cases of recent onset of seizures in
the above three neighboring districts of Andhra Pradesh. In
order to supplement the clinical suspicion of NCC, usefulness
of a serological test detecting antibody by ELISA in addition
to brain imaging is discussed.2. Materials and methods
2.1. Patients
The present study was conducted in Andhra Medical Col-
lege Hospital in Visakhapatnam, a major tertiary care health-
care establishment in the study area, serving the populations
most commonly from Visakhapatnam, Vizianagaram and Sri-
kakulam districts of Andhra Pradesh (Figure 1). A total of 160
patients were recruited in the present study. The majority of
which were from neurology, general medicine, or pediatrics
outpatient clinics of the above hospital during the period of
2011–2014, and rest were referral cases from other corporate
hospitals in the same locality. Informed consent was obtained
from patients or legal guardians of each of the study subjects.
Detailed history was collected from patients and/or guardians
and a routine clinical examination was conducted before to
include them for this study. Screening of anti-cysticercus an-
tibodies in serum was performed as stated in Section 2.4. All
samples were analyzed in one laboratory employing same
protocol.2.1.1. Inclusion criteria
Seizure patients clinically and/or radiologically suspected to be
NCC,within age range of 3–65years, and living in any of the above
three districts of Andhra Pradesh for at least a year were included.
2.1.2. Exclusion criteria
Patients not living in the study area for a year or short term
tourists/visitors, of age range either < 2 years or > 65 years,
suspected female patients with detection of underlying pregnancy
were excluded. Also patients having past history of head injury,
symptoms of febrile seizures in children, recent history of any
other chronic disease excluded from the present screening study.
2.2. Brain imaging
Brain imaging by CT or magnetic resonance imaging (MRI)
was performed in all cases. The study subjects were initially
hypothesized as possible cases of NCC based on two minor plus
one epidemiological criterion as per the revised diagnostic
criteria suggested by Del Brutto [1].
2.3. Specimen
Under aseptic precautions, 3 mL of venous blood was
collected from all the recruited patients upon written consent.
The collected whole blood sample from each case was allowed
to clot at room temperature. The serum was separated and then
stored in pair at −80 C till use.
2.4. T. solium immunoglobulin G (IgG) ELISA in serum
A commercially procured ELISA Kit (NovaTec Diagnostics,
Germany) was employed for detection of anti-cysticercus IgG
antibodies in sera from all the recruited cases following manu-
facturer's instructions. Brieﬂy, antigen coated wells supplied by
the kit manufacturer were incubated with 1:10 diluted patient/
control serum (diluted with the serum diluent ﬂuid provided in
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positive control serum (all reagents supplied by the manufac-
turer) were also used for validity of the test. Absorbance was
measured at 450 nm. A sample was considered positive for anti-
T. solium antibody when the optical density value was estimated
to be more than that of the low positive control serum. The
sensitivity and speciﬁcity of the above ELISA for anti-
cysticercus antibody detection in serum were previously esti-
mated to be 85% and 94% respectively based on results of the
test using sera from a group of known cases (cases with a
deﬁnitive diagnosis of NCC) and another group comprising
healthy normal individuals as described in an earlier study [17].
3. Results
In this study, a total of 55% cases presented with generalized
seizures, whereas the seizure type was simple partial and complex
partial in 31.25% and 13.75% of cases, respectively (Table 1).
The two-tailed P value was calculated to be equivalent to 0.7235
when the seropositivity results were analyzed comparing two
groups of patients who presented either with generalized or
partial seizures (simple and complex partial seizures combined).
Based on CT and/or MRI ﬁndings, 85 seizure patients had
solitary lesion in brain. A total of 75 had multiple lesions which
included 37 cases with 2–4 lesions, and 38 with > 4 lesions
(Table 2). The association between seropositivity for NCC, and
the number of lesions in brain was found to be not statistically
signiﬁcant since the two-tailed P value was estimated to be
0.4786.Table 1
Results of the anti-cysticercus IgG-ELISA in seizure patients with
different type of seizure.
Type of seizure No. of patients
recruited
Anti-cysticercus IgG-ELISA
[n (%)]
Sera tested
positive
Sera tested
negative
Generalized
seizures
88 23 (26.1) 65 (73.9)
Simple partial
seizures
50 16 (32.0) 34 (68.0)
Complex partial
seizures
22 5 (22.7) 17 (77.3)
Total 160 44 (27.5) 116 (72.5)
Statistical analysis was done using GraphPad QuickCalc online statis-
tical tool.
Table 2
Results of the anti-cysticercus IgG-ELISA in seizure patients with respect
to CT and MRI scan imaging features.
Number of
lesions in brain
No. of patients
recruited
Anti-cysticercus IgG-ELISA
[n (%)]
Sera tested
positive
Sera tested
negative
Single lesion 85 21 (24.7) 64 (75.3)
2–4 lesions 37 9 (24.3) 28 (75.7)
Multiple lesions 38 14 (36.8) 24 (63.2)
Total 160 44 (27.5) 116 (72.5)
Statistical analysis was done using GraphPad QuickCalc online statis-
tical tool.The distribution of lesions in various parts of brain is pre-
sented in Table 3. In this series, the lesions were most common
in parietal lobe followed by frontal lobe, occipital, temporal
lobes and other regions like basal ganglia, ventricles etc. How-
ever, percentage of seropositive cases was comparable. Presence
of either single or multiple lesions and characteristics of lesions
are presented in Table 4. In this series, majority had granular
nodular cysts with inﬂammation (17 cases single + 8 cases
multiple = total 25 cases). Only calciﬁed cysts were seen in a
total of 7 cases (i.e. 2 cases with single lesion + 5 cases with > 1
lesions) and single vesicular lesions in 2 cases. The age range of
these cases was found to be between 4 and 65 years and there
were 60% males and 40% females.
In serological analysis, total 27.5% of patients were found
positive for anti-cysticercus IgG antibodies. Among the positive
sera tested, 26.1% had generalized seizures, 32.0% had simple
partial seizures and 22.7% had complex partial seizures
(Table 1). Among other complaints of these seropositive pa-
tients, headache was major complaint accounting for 30.7%,
vomiting 40%, hemiparesis 36.4%, muscle weakness 33.3% and
altered sensorium 28.6% (Figure 2).
In this study, 24.7% of seropositive cases had single lesion,
24.3% had 2–4 lesions and 36.8% had multiple lesions
(Table 2). In this screening study, CT and/or MRI scan revealed
presence of lesions in all seropositive cases. Among these
seropositive cases, 27.9% of lesions were seen in the parietal
lobe, 28.1% in the frontal lobe and fronto-parietal lobes, 15.0%
in occipital and parieto-occipital lobes, 34.3% in all regions and
25.0% in other parts of the brain (Table 3). Further character-
istics of the brain lesions are shown in Table 4. In this series,Table 3
Results of the anti-cysticercus IgG-ELISA in seizure patients with respect
to location of lesions in the brain.
Location of lesion
in brain
No. of patients
recruited
Anti-cysticercus IgG-ELISA
[n (%)]
Sera tested
positive
Sera tested
negative
Parietal lobes 61 17 (27.9) 44 (72.1)
Frontal lobes and
fronto-parietal
32 9 (28.1) 23 (71.9)
Occipital lobe and
parieto-occipital
20 3 (15.0) 17 (85.0)
All regions 35 12 (34.3) 23 (65.7)
Other regions like
temporal lobes, basal
ganglia, ventricles
12 3 (25.0) 9 (75.0)
Total 160 44 (27.5) 116 (72.5)
Table 4
Type or stage of the lesion in the cases tested positive by the anti-
cysticercus IgG-ELISA [n (%)].
Number of lesion Lesion type Sera tested
positive
Single lesion Vesicular 2 (4.5)
Granular nodular
(with inﬂammation)
17 (38.6)
Calciﬁed granuloma 2 (4.5)
> 1 lesions Granular nodular
(with inﬂammation) + calciﬁed
8 (18.1)
Calciﬁed granuloma 5 (11.4)
All stages 10 (22.7)
Total no of positive cases 44
Generalized 
seizures
Simple partial 
seizures
Complex partial 
seizures
Headache
No. of cases out of 160 recruited
88
23
50
16
22
5
88
27
20
8 4 4 3
11
17
9 7
2
No. of cases out of 44 cases positive for antibody
Vomiting Hemiparesis Muscle 
weakness
Unconsciousness Altered 
sensorium
Figure 2. Distribution of clinical signs/symptoms, and seizure pattern in afebrile seizure cases diagnosed to be positive for anti-cysticercus IgG-ELISA vs.
all the recruited cases.
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inﬂammation around either single (17 cases) or multiple (8
cases) lesions (total 25 cases); calciﬁed cysts in 7 cases and
vesicular stage in 2 cases were also detected. Among the sero-
positive cases, 10 cases had multiple cysts with different stages
of development.
In this study, 70.45% of seropositive cases were identiﬁed to
be from low socioeconomic background, and 29.55% were from
high socioeconomic background. Of these, 68.1% were residing
in rural areas and 31.8% were residing in urban area. In 44
seropositive cases, 45.45% had history of pork consumption.
4. Discussion
NCC is considered to be a major public health problem in
India. NCC has been suspected as a major deﬁnable risk of epi-
lepsy in this country [18]. However, information about its
prevalence is either lacking or incompletely recorded even if the
whole country is assumed to be highly endemic for T. solium
taeniasis/cysticercosis. The north coastal districts of Andhra
Pradesh were never explored before. This is the ﬁrst ever study
in these three neighboring districts of Andhra Pradesh where the
proportion of PWE suffering from NCC is estimated and also
the possible associated factors are discussed here. For the ﬁrst
time, a series of cases from the hospital-based screening, as in
this study, revealed more than one fourth of the total number of
cases presenting with seizures due to the NCC that was evident
based on the serum antibody reactivity as well as CT/MRI brain
ﬁndings compatible with it. Therefore, by detection of anti-
cysticercus IgG antibodies in serum, the possible potentiality of
NCC can be identiﬁed as an underlying cause of the recent onset
of seizures in this region. There were few earlier studies from
other Indian provinces which showed similar levels of occurrence
of cysticercosis as a cause of acquired seizure [19].
The result of the present study was similar to most of the
other studies reported earlier. In our study, majority of the
seizure cases were in pediatric age group in contrast to adults.
Researchers from other parts have also reported more cases in
pediatric age group [20–23]. Parija and Raman reported
predominance between 16 and 48 age group [22]. In an earlier
study, the predominant age group was found to be ranging
between 30 and 49 years [24]. In the study of Kotokey et al.,
the predominant age group was between 21 and 30 [25].
Whereas, other two recent studies reported the predominant
age group as 10–65 and 8–60, respectively [26,27].In present study, females were predominant than males with
percentage of 34.4%. In an earlier study, females were reported
to be predominant (58%) than males [20]. In other studies, also
males were predominant than females [21,23]. In some other
studies, also males were diagnosed predominantly accounting
53%–95% in different regions [24,26,27].
Predominance of type of seizures in seropositive NCC pa-
tients in different studies shows generalized seizures are more
commonly than the partial seizures. In present study, simple
partial seizures are predominant with 31.25%. In other studies,
also generalized seizures were the predominant type [20,21,23,27].
Hence, the result of present study was contradictory to most of
the other studies reported earlier.
In the present study, headache is predominant followed by
vomiting, hemiparesis, muscle weakness and altered sensorium.
In our earlier studies [16,23], headache was predominant followed
by vomiting, pallor, altered sensorium, and muscle weakness.
Headache was predominant followed by mental retardation,
and psychiatric symptoms in another study reported elsewhere
[21]. Similarly, headache was also predominant accounting for
15.6% as documented from another recent study [28].
In the present study, multiple lesions in all regions of brain are
predominant with percentage of 36.8% and 34.33%, respectively.
In other similar studies, multiple lesions in parietal regions were
predominant with 42.85% and 34.32%, respectively [23]. Thus,
results of the present study were similar to other studies
reported earlier.
In this case series, the granular nodular lesions with inﬂam-
mation were predominant with percentage of 38.6%. In a recent
study from Odisha, a state neighboring to Andhra Pradesh, calci-
ﬁed cysts were predominant, accounting for 47.06% of the total
patients diagnosed to be NCC [23]. In other studies, either mixed
lesions, or immunologically active lesions were reported to be
predominant [29,30]. Hence, the results of our study were found
to be in accordance with ﬁndings from other Indian studies.
In the present study, 45.4% of seropositive cases have history
of pork consumption. In other studies, 91.3% of seropositive
cases had a history of pork consumption [26]. This may be due to
cultural differences or difference in dietary habits of populations
in different parts of the world.
Both, NCC and epilepsy, are an increasing burden on the
welfare and economy of developing countries [5,31]. In the
present study, 70.4% of seropositive cases belong to low
socioeconomic status, i.e. yearly income < 2 lakhs and 29.6%
belong to high socioeconomic status. The results of present
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belong to low socioeconomic status and 11.1% belong to high
socioeconomic status [28]. Similar ﬁndings were also reported
from an epidemiological study report from the incidences in a
recent study from Malaysia [32].
In the present study, 68.1% belong to rural area and 31.9%
belong to urbanareawhichcoincideswith the studyofKirmani et al.
inwhich 60%belong to rural area and 40%belong to urban area [28].
In an earlier study from a rural medical college hospital in Andhra
Pradesh, 18 cases of cysticercus cellulose at rare sites were
reported. Out of total 18, 15 cases had parasite located in the
subcutaneous tissue of chest wall, breast, left lumbar region,
umbilicus, abdominal wall, back, extremities, and neck region;
there were 2 cases with cysticercus larvae in eye and 1 case had a
cyst detected in the oral cavity [13]. There was a case of orbital
cysticercosis in Vishakhapatnam where a small cysticercus cyst of
the superior rectus muscle was detected by CT [33]. Cysticercosis
in eye has been also reported from various other locations in
Andhra Pradesh including the latest report of a retrobulbar optic
nerve cysticercosis [34].
Nevertheless, the prevalence of anti-cysticercus antibodies
detected in sera from the present series of cases with seizure may
not be the true picture if the ﬁgures are extrapolated to a larger
population in the same territory or even the whole province of
Andhra Pradesh in India. The commercially procured ELISA kit
detects antibodies against antigens of the parasite which are not
deﬁned or not declared by the manufacturer as stated earlier [23].
Therefore, further study screening antibodies speciﬁc to more
deﬁned antigens of the larval parasite might result in different
prevalence scenario.
Management of NCC needs to be individualized as recom-
mended elsewhere [35]. Recent literatures emphasize the need for
focused and targeted programs which also encourage for stronger
public health approach based on equity for prevention, control,
and management of epilepsy in India [36].
This is the ﬁrst hospital-based report of a series of NCC cases
from three neighboring districts of Andhra Pradesh in India where
the burden of seizures due to NCC was never explored before. In
our study, NCC is found to be more common in females with low
socioeconomic status living in rural area with partial seizures.
Detecting anti-cysticercus IgG antibodies in serum could reveal the
potentiality of possibleNCC as an underlying cause of recent onset
seizures in the studied cases.Although, theCT/MRI scan is a potent
diagnostic tool compared to antibody detection, the diagnostic
decision can be better made if both the modalities are considered
together.However, it is recommended to suspectNCCas oneof the
major differential, and so it shouldbe ruled out in every recent onset
seizure case, with or without an imaging based supportive diag-
nosis, especially in the regions which are endemic for T. solium
taeniasis/cysticercosis.
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